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The title compound, C22H20ClN3O, (I), is used as an
intermediate for the synthesis of the antihypertensive drug
losartan. Bond lengths and angles are unexceptional. The
crystal packing is stabilized by one C—H  O and one C—
H  N contact. It is noteworthy that (I) is isomorphous with a
closely related compound which differs in having a but-2-enyl
chain instead of a butyl chain on the imidazole ring.
Comment
Imidazole derivatives have applications in pharmaceuticals,
agrochemicals, dyestuffs and high-temperature polymer
products (Nagaraj et al., 2005).
Imidazole is a fundamental building block of many proteins
and other biological systems. It also acts as a ligand that will
bind readily to a metal ion in aqueous systems. A survey of the
literature reveals that the crystal structure of a closely related
compound, namely 40-{[2-(but-2-enyl)-4-chloro-5-formyl-
imidazol-1-yl]methyl}biphenyl-2-carbonitrile, (II), has been
reported recently (Malathy Sony et al., 2005). The only
difference between the two structures is that the imidazole
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Figure 1
A perspective view of (I) with the atom-numbering scheme. Displace-
ment ellipsoids are drawn at the 50% probability level.
ring in the title compound, (I), carries a butyl chain, whereas
(II) carries a but-2-enyl chain.
The title compound is used as a key intermediate for the
synthesis of the antihypertensive drug losartan (Griffiths et al.,
1999). In a continuation of our work on derivatives of
imidazole (Yathirajan et al., 2005), and in order to establish the
conformation of the title compound, the crystal structure
determination was carried out.
A perspective view of (I) is shown in Fig. 1. Bond lengths
and angles can be regarded as normal (Cambridge Structural
Database, Version 1.7; MOGUL, Version 1.0.1; Allen, 2002).
The dihedral angle between the two benzene rings is 41.36 (5)
[41.64 (12) in (II)]. The imidazole ring and the central
benzene ring (C11–C16) enclose an angle of 72.03 (5)
[73.28 (14) in (II)]. The carbonyl group is almost coplanar
with the imidazole ring [N1—C2—C10—O10 = 2.8 (2)]. The
butyl chain exhibits an all-trans conformation. The plane
containing the four butyl C atoms forms an angle of
24.28 (10) with the imidazole ring. The repulsion between the
Cl atom and the formyl H atom leads to significantly different
exocyclic angles at C3. On the other hand, the exocyclic angles
at N1, C2 and C5 are rather similar (Table 1). The equivalent
angles in (II) show the same phenomenon. There is one C—
H  O and one C—H  N contact (Table 2).
A least-squares fit (r.m.s. deviation 0.052 A˚) of (I) with (II),
fitting all non-H atoms excluding the butyl chain (Fig. 2),
shows that there are only minor differences between the two
molecular conformations. The structures of (I) and (II) are
isomorphous. The cell dimensions of (I) are slightly smaller
than those of (II) [a = 9.080 (6) A˚, b = 22.782 (15) A˚, c =
10.055 (7) A˚,  = 109.476 (19) and V = 1961 (2) A˚3], but this
may be due to the fact that the data collection for (II) was
performed at room temperature.
Experimental
An equimolar mixture of 2-butyl-5-chloro-3H-imidazole-4-carbox-
aldehyde (1.86 g, 0.01 mol), 40-(bromomethyl)biphenyl-2-carbonitrile
(2.72 g, 0.01 mol) and anhydrous K2CO3 (1.66 g, 0.01 mol) was stirred
in a dimethylformamide (10 ml) medium for 10 h. The mixture was
quenched with water and the product formed was extracted with
dichloromethane (25 ml). The solvent was then removed and the
product formed was recrystallized (m.p. 372 K) from methanol
(Smith et al., 1994).
Crystal data
C22H20ClN3O
Mr = 377.86
Monoclinic, P21=c
a = 8.9729 (4) A˚
b = 22.6232 (9) A˚
c = 9.9288 (5) A˚
 = 106.427 (4)
V = 1933.23 (15) A˚3
Z = 4
Dx = 1.298 Mg m
3
Mo K radiation
Cell parameters from 35 462
reflections
 = 2.4–27.9
 = 0.21 mm1
T = 173 (2) K
Block, colourless
0.32  0.25  0.22 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
! scans
Absorption correction: multi-scan
(MULABS; Spek, 2003; Blessing,
1995)
Tmin = 0.923, Tmax = 0.955
31 411 measured reflections
4448 independent reflections
4037 reflections with I > 2(I)
Rint = 0.044
max = 27.7

h = 11 ! 11
k = 29 ! 29
l = 12 ! 12
Refinement
Refinement on F 2
R[F 2 > 2(F 2)] = 0.042
wR(F 2) = 0.112
S = 1.05
4448 reflections
244 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.053P)2
+ 0.8177P]
where P = (Fo
2 + 2Fc
2)/3
(/)max = 0.001
max = 0.51 e A˚
3
min = 0.42 e A˚3
Table 1
Selected geometric parameters (A˚, ).
Cl1—C3 1.7179 (14)
N1—C5 1.3544 (17)
N1—C2 1.3969 (17)
C2—C3 1.384 (2)
C3—N4 1.3495 (19)
N4—C5 1.3401 (17)
C10—O10 1.218 (2)
C14—C21 1.4875 (17)
C22—C27 1.4409 (19)
C27—N27 1.146 (2)
C5—N1—C2 107.39 (11)
C5—N1—C1 125.69 (11)
C2—N1—C1 126.91 (11)
C3—C2—N1 103.43 (12)
C3—C2—C10 128.72 (13)
N1—C2—C10 127.83 (13)
N4—C3—C2 112.82 (12)
N4—C3—Cl1 120.31 (11)
C2—C3—Cl1 126.87 (11)
C5—N4—C3 104.30 (12)
N4—C5—N1 112.07 (12)
N4—C5—C6 123.76 (12)
N1—C5—C6 124.17 (12)
Table 2
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
C1—H1B  O10 0.99 2.41 3.0642 (18) 123
C6—H6A  N27i 0.99 2.56 3.5312 (19) 166
Symmetry codes: (i) x þ 1; y; z.
All H atoms were located in a difference map but were subse-
quently positioned geometrically and refined with fixed individual
displacement parameters (set at 1.2Ueq of the parent atom, or 1.5Ueq
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Figure 2
Least-squares fit of (I) (open bonds) with (II) (solid bonds).
for methyl groups) using a riding model (C—H = 0.95, 0.98 and
0.99 A˚ for aromatic, methyl and methylene H atoms, respectively).
Data collection: X-AREA (Stoe & Cie, 2001); cell refinement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1997); program(s) used to refine
structure: SHELXL97 (Sheldrick, 1997); molecular graphics:
PLATON (Spek, 2003); software used to prepare material for
publication: PLATON and SHELXL97.
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